Telescope Innovations Corp. engages in the development and manufacture of chemical technologies for pharmaceuticals and chemical industries. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-09-27. The firm is developing scalable manufacturing processes and tools for the pharmaceutical and chemical industries. The firm builds and deploys new enabling technologies, including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Its flagship product is the DirectInject-LC system. DirectInject-L (Liquid Chromatography) connects live reactions to industry-standard analytical instruments. Its hardware and software ecosystem enables direct sampling and analysis of chemical reactions. The company enables unattended sample capture, quenching, dilution, and analysis using a variety of industry standard CDS platforms, including Agilent OpenLab, Agilent ChemStation, Waters Empower 3, and Shimadzu LabSolutions.
Follow-Up Questions
Telescope Innovations Corp のCEOは誰ですか？
Prof. Jason Hein は Telescope Innovations Corp の Chief Executive Officer で、2021 から在籍しています。
